Penetrium Bioscience tests new combination cancer treatment with Merck's Keytruda
South Korea's Penetrium Bioscience said Wednesday that the company would start a clinical test combining its investigational cancer drug Penetrium with Merck's immunotherapy Keytruda.
6/17/2026 8:28:26 AM